The 20th edition of the EY Pulse of the MedTech Industry Report captures the medical devices sector at both a high point and a turning point. Learn more about multiple areas where key strategic moves have become critical to industry value:
- Making the right portfolio decisions to secure inorganic growth and investment into core growth areas, while ensuring that divested businesses find the right owners.
- Investing effectively in R&D to achieve productivity that genuinely translates into profitability, and improved total shareholder returns (TSR).
- Helping companies capture the opportunities from emerging high-growth channels, in particular the booming ambulatory surgical center (ASC) market.
- Investing to embed AI into MedTech architecture in ways that can unlock new sources of value rather than just experimenting at the edges of the business model.